Chinese drug manufacturer Biostar Pharmaceuticals (BSPM +10%) jumps after signing a Letter of Intent with the Fourth Military Medical University in China to jointly carry out clinical trials for the Viacom Pine II Cream, a drug that treats skin diseases such as bacterial and fungal infections. The letter has been turned in to China's military authorities and is awaiting consent.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs